F-star lines up Take­da pact weeks af­ter M&A ex­it; En route to Eu­rope de­ci­sion, Gen­Sight touts 5-year da­ta

Weeks af­ter wrap­ping up a month­s­long search for a new own­er, F-star Ther­a­peu­tics has signed a li­cens­ing agree­ment with Take­da for a new im­muno-on­col­o­gy bis­pe­cif­ic …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER